These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34259144)

  • 1. Beneficial Effects of Liposomal Formulations of Lichen Substances: A Review.
    Tatipamula VB; Nguyen HT; Kukavica B
    Curr Drug Deliv; 2022; 19(3):252-259. PubMed ID: 34259144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary metabolites from cetrarioid lichens: Chemotaxonomy, biological activities and pharmaceutical potential.
    Xu M; Heidmarsson S; Olafsdottir ES; Buonfiglio R; Kogej T; Omarsdottir S
    Phytomedicine; 2016 May; 23(5):441-59. PubMed ID: 27064003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal Avicequinone-B formulations: Aqueous solubility, physicochemical properties and apoptotic effects on cutaneous squamous cell carcinoma cells.
    Hu SC; Su YS; Lai YC; Tseng CH; Yen FL
    Phytomedicine; 2019 May; 58():152870. PubMed ID: 30903942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High acidity tolerance in lichens with fumarprotocetraric, perlatolic or thamnolic acids is correlated with low pKa1 values of these lichen substances.
    Hauck M; Jürgens SR; Huneck S; Leuschner C
    Environ Pollut; 2009 Oct; 157(10):2776-80. PubMed ID: 19464777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
    Azanza JR; Sádada B; Reis J
    Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen secondary metabolites affect growth of Physcomitrella patens by allelopathy.
    Goga M; Antreich SJ; Bačkor M; Weckwerth W; Lang I
    Protoplasma; 2017 May; 254(3):1307-1315. PubMed ID: 27645140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation.
    Kumar R; Singh B; Bakshi G; Katare OP
    Pharm Dev Technol; 2007; 12(6):591-601. PubMed ID: 18161632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Liposomal Drug Formulations on the RBCs Shape, Transmembrane Potential, and Mechanical Properties.
    Cyboran-Mikołajczyk S; Sareło P; Pasławski R; Pasławska U; Przybyło M; Nowak K; Płóciennik M; Podbielska H; Kopaczyńska M; Wawrzyńska M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa.
    Pushparaj Selvadoss P; Nellore J; Balaraman Ravindrran M; Sekar U; Tippabathani J
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):268-273. PubMed ID: 28362119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect.
    Hanato J; Kuriyama K; Mizumoto T; Debari K; Hatanaka J; Onoue S; Yamada S
    Int J Pharm; 2009 Dec; 382(1-2):111-6. PubMed ID: 19698772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic properties of lichen secondary metabolites.
    Ulus G
    Phytother Res; 2021 Jun; 35(6):3046-3058. PubMed ID: 33587324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Formulation Improves the Bioactivity of Usnic Acid in RAW 264.7 Macrophage Cells Reducing its Toxicity.
    Vasarri M; Ponti L; Degl'Innocenti D; Bergonzi MC
    Curr Drug Deliv; 2024; 21(1):91-103. PubMed ID: 36631924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal drug formulations in the treatment of rheumatoid arthritis.
    van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G
    Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.